QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

Pactiv Evergreen (PTVE) Insider Trading & Ownership

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free ptve Stock Alerts
$14.52
+0.38 (+2.69%)
(As of 04:38 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Pactiv Evergreen (NASDAQ:PTVE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.43%
Number Of
Insiders Buying
(Last 3 Years)
5
Amount Of
Insider Buying
(Last 3 Years)
$768,033.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get PTVE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pactiv Evergreen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PTVE Insider Buying and Selling by Quarter

Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

Pactiv Evergreen Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/16/2022Rolf StanglDirectorBuy5,000$9.38$46,900.00  
6/14/2022Allen HugliDirectorBuy5,100$9.68$49,368.00  
6/10/2022Tim A LevendaInsiderBuy10,000$10.00$100,000.00  
4/1/2022Eric WulfInsiderBuy10,000$10.00$100,000.00  
3/1/2022Allen HugliDirectorBuy8,500$9.23$78,455.00  
6/17/2021Michael Jack KingCEOBuy9,134$15.00$137,010.00  
6/14/2021Michael Jack KingCEOBuy10,000$15.41$154,100.00  
5/14/2021Rolf StanglDirectorBuy7,000$14.60$102,200.00  
(Data available from 1/1/2013 forward)

PTVE Insider Trading Activity - Frequently Asked Questions

Who is on Pactiv Evergreen's Insider Roster?

The list of insiders at Pactiv Evergreen includes Allen Hugli, Eric Wulf, Michael Jack King, Rolf Stangl, and Tim A Levenda. Learn more on insiders at PTVE.

What percentage of Pactiv Evergreen stock is owned by insiders?

0.43% of Pactiv Evergreen stock is owned by insiders. Learn more on PTVE's insider holdings.

Which Pactiv Evergreen insiders have been buying company stock?

The following insiders have purchased PTVE shares in the last 24 months: Allen Hugli ($49,368.00), Rolf Stangl ($46,900.00), and Tim A Levenda ($100,000.00).

How much insider buying is happening at Pactiv Evergreen?

Insiders have purchased a total of 20,100 PTVE shares in the last 24 months for a total of $196,268.00 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:PTVE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative